Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005796
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2000-06-02
Brief Title:
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Sponsor:
Indiana University
Organization:
Indiana University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| DrugAgent Toxicity by TissueOrgan |
| Bone Marrow Suppression |
| Brain and Central Nervous System Tumors |
Keywords:
| Name | View |
|---|---|
| adult gliosarcoma | View |
| recurrent adult brain tumor | View |
| adult brain stem glioma | View |
| adult ependymoma | View |
| adult medulloblastoma | View |
| adult glioblastoma | View |
| childhood high-grade cerebral astrocytoma | View |
| childhood oligodendroglioma | View |
| adult anaplastic astrocytoma | View |
| adult anaplastic oligodendroglioma | View |
| adult mixed glioma | View |
| drugagent toxicity by tissueorgan | View |
| bone marrow suppression | View |
| untreated childhood brain stem glioma | View |
| recurrent childhood brain stem glioma | View |
| untreated childhood cerebellar astrocytoma | View |
| recurrent childhood cerebellar astrocytoma | View |
| recurrent childhood cerebral astrocytoma | View |
| recurrent childhood medulloblastoma | View |
| newly diagnosed childhood ependymoma | View |
| recurrent childhood ependymoma | View |
| adult giant cell glioblastoma | View |